Literature DB >> 28403765

The Australasian Society for Infectious Diseases and Refugee Health Network of Australia recommendations for health assessment for people from refugee-like backgrounds: an abridged outline.

Nadia J Chaves1, Georgia A Paxton2, Beverley-Ann Biggs3, Aesen Thambiran4, Joanne Gardiner5, Jan Williams6, Mitchell M Smith7, Joshua S Davis8.   

Abstract

INTRODUCTION: In 2009, the Australasian Society of Infectious Diseases published guidelines on the post-arrival health assessment of recently arrived refugees. Since then, the number of refugees and asylum seekers reaching Australia has increased substantially (17 555 refugees in 2015-16) and the countries of origin have changed. These groups are likely to have had poor access to health care pre-arrival and, consequently, are at risk of a range of chronic and infectious diseases. We established an advisory group that included infectious diseases physicians, general practitioners, public health specialists, paediatricians and refugee health nurses to update the 2009 guidelines.Main recommendations: All people from refugee-like backgrounds, including children, should be offered a tailored comprehensive health assessment and management plan, ideally within 1 month of arrival in Australia. This can be offered at any time if initial contact with a GP or clinic is delayed. Recommended screening depends on history, examination and previous investigations, and is tailored based on age, gender, countries of origin and transit and risk profile. The full version of the guidelines is available at http://www.asid.net.au/documents/item/1225.Changes in management as a result of this guideline: These guidelines apply to all people from refugee-like backgrounds, including asylum seekers. They provide more information about non-communicable diseases and consider Asia and the Middle East as regions of origin as well as Africa. Key changes include an emphasis on person-centred care; risk-based rather than universal screening for hepatitis C virus, malaria, schistosomiasis and sexually transmissible infections; updated immunisation guidelines; and new recommendations for other problems, such as nutritional deficiencies, women's health and mental health.

Entities:  

Mesh:

Year:  2017        PMID: 28403765     DOI: 10.5694/mja16.00826

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  13 in total

1.  Migrant Healthcare Guidelines: A Systematic Quality Assessment.

Authors:  Eric Nwachukwu Agbata; Paulina Fuentes Padilla; Ifeoma Nwando Agbata; Laura Hidalgo Armas; Ivan Solà; Kevin Pottie; Pablo Alonso-Coello
Journal:  J Immigr Minor Health       Date:  2019-04

2.  The diagnosis and treatment of urogenital schistosomiasis in Italy in a retrospective cohort of immigrants from Sub-Saharan Africa.

Authors:  Marta Tilli; Federico Gobbi; Francesca Rinaldi; Jacopo Testa; Silvio Caligaris; Paola Magro; Dora Buonfrate; Monica Degani; Andrea Minervini; Marco Carini; Agostino Tuccio; Simone Sforza; Maurizio Gulletta; Francesco Castelli; Simone Agostini; Filippo Parretti; Joachim Richter; Piero Olliaro; Zeno Bisoffi; Alessandro Bartoloni; Lorenzo Zammarchi
Journal:  Infection       Date:  2019-01-21       Impact factor: 3.553

3.  Integrating testing for chronic strongyloidiasis within the Indigenous adult preventive health assessment system in endemic communities in the Northern Territory, Australia: An intervention study.

Authors:  Wendy A Page; Jenni A Judd; David J MacLaren; Petra Buettner
Journal:  PLoS Negl Trop Dis       Date:  2020-05-13

Review 4.  [Recommendations for the screening for infectious diseases, mental health, and female genital mutilation in immigrant patients seen in Primary Care].

Authors:  Ethel Sequeira-Aymar; Ximena diLollo; Yolanda Osorio-Lopez; Alessandra Queiroga Gonçalves; Carme Subirà; Ana Requena-Méndez
Journal:  Aten Primaria       Date:  2019-04-25       Impact factor: 1.137

Review 5.  EMERGING INFECTIOUS DISEASES - OVERVIEW.

Authors:  Robin B McFee
Journal:  Dis Mon       Date:  2018-03-07       Impact factor: 3.800

6.  Improving screening and management of latent tuberculosis infection: development and evaluation of latent tuberculosis infection primary care model.

Authors:  Marina Kunin; Mark Timlin; Chris Lemoh; David A Sheffield; Alana Russo; Shegofa Hazara; Jacqueline McBride
Journal:  BMC Infect Dis       Date:  2022-01-12       Impact factor: 3.090

7.  Intestinal parasites in stool testing among refugees at a primary care clinic in Toronto, Canada.

Authors:  Frank Müller; Shivani Chandra; Isaac I Bogoch; Meb Rashid; Vanessa Redditt
Journal:  BMC Infect Dis       Date:  2022-03-13       Impact factor: 3.090

8.  Prevention and assessment of infectious diseases among children and adult migrants arriving to the European Union/European Economic Association: a protocol for a suite of systematic reviews for public health and health systems.

Authors:  Kevin Pottie; Alain D Mayhew; Rachael L Morton; Christina Greenaway; Elie A Akl; Prinon Rahman; Dominik Zenner; Manish Pareek; Peter Tugwell; Vivian Welch; Joerg Meerpohl; Pablo Alonso-Coello; Charles Hui; Beverley-Ann Biggs; Ana Requena-Méndez; Eric Agbata; Teymur Noori; Holger J Schünemann
Journal:  BMJ Open       Date:  2017-09-11       Impact factor: 2.692

Review 9.  Accessibility and Acceptability of Infectious Disease Interventions Among Migrants in the EU/EEA: A CERQual Systematic Review.

Authors:  Matt Driedger; Alain Mayhew; Vivian Welch; Eric Agbata; Doug Gruner; Christina Greenaway; Teymur Noori; Monica Sandu; Thierry Sangou; Christine Mathew; Harneel Kaur; Manish Pareek; Kevin Pottie
Journal:  Int J Environ Res Public Health       Date:  2018-10-23       Impact factor: 3.390

10.  Comprehensive infectious disease screening in a cohort of unaccompanied refugee minors in Germany from 2016 to 2017: A cross-sectional study.

Authors:  Ales Janda; Kristin Eder; Roland Fressle; Anne Geweniger; Natalie Diffloth; Maximilian Heeg; Nadine Binder; Ana-Gabriela Sitaru; Jan Rohr; Philipp Henneke; Markus Hufnagel; Roland Elling
Journal:  PLoS Med       Date:  2020-03-31       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.